Repligen Corporation (RGEN)
Repligen Statistics
Share Statistics
Repligen has 56.18M shares outstanding. The number of shares has increased by 0.27% in one year.
| 56.18M |
| 0.27% |
| 0% |
| 99.99% |
| 53.12M |
| 55 |
| 0.01% |
Short Selling Information
The latest short interest is 3.45M, so 6.14% of the outstanding shares have been sold short.
| 3.45M |
| 6.14% |
| 8.28% |
| 4.43 |
Valuation Ratios
The PE ratio is -315.57 and the forward PE ratio is 60.46. Repligen's PEG ratio is 1.84.
| -315.57 |
| 60.46 |
| 12.69 |
| 5.7 |
| 4.08 |
| 56.51 |
| 1.84 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Repligen.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 8.41, with a Debt / Equity ratio of 0.35.
| 8.41 |
| 8.41 |
| 0.35 |
| 8.36 |
| 4.82 |
| -1.56 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $356,827.33 |
| $-14,349.83 |
| 1,778 |
| 0.22 |
| n/a |
Taxes
| -1.52M |
| 5.63% |
Stock Price Statistics
The stock price has increased by 1.53% in the last 52 weeks. The beta is 1.11, so Repligen's price volatility has been higher than the market average.
| 1.11 |
| 1.53% |
| 128.14 |
| 142.7 |
| 49.51 |
| 826,847 |
Income Statement
In the last 12 months, Repligen had revenue of 634.44M and earned -25.51M in profits. Earnings per share was -0.46.
| 634.44M |
| 274.64M |
| -35.11M |
| -25.51M |
| 82.1M |
| -6.3M |
| -0.46 |
Balance Sheet
The company has 757.36M in cash and 686.25M in debt, giving a net cash position of 71.11M.
| 757.36M |
| 686.25M |
| 71.11M |
| n/a |
| 2.85B |
| 880.47M |
Cash Flow
In the last 12 months, operating cash flow was 175.39M and capital expenditures -32.91M, giving a free cash flow of 142.49M.
| 175.39M |
| -32.91M |
| 142.49M |
| 2.55 |
Margins
Gross margin is 43.29%, with operating and profit margins of -5.53% and -4.02%.
| 43.29% |
| -5.53% |
| -4.26% |
| -4.02% |
| 12.94% |
| -5.53% |
| 22.46% |
Dividends & Yields
RGEN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for RGEN is $180, which is 41.1% higher than the current price. The consensus rating is "Buy".
| $180 |
| 41.1% |
| Buy |
| 12 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 5.61 |
| 5 |